Topical Tapinarof Reduces Severity of Plaque Psoriasis
Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.